Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
about
Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?Drug-induced liver injury: Towards early prediction and risk stratificationCarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods.Drug safety: withdrawn medications are only part of the picturePost-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic reviewPredicting drug-drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge.Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014)Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis.Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluationImportance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and TherapeuticsMedicine and the future of health: reflecting on the past to forge ahead.Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Platform for Testing For Drug Cardiotoxicity.SuperDRUG2: a one stop resource for approved/marketed drugs.Medicines Regulation in Africa: Current State and Opportunities.Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety.Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation.Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms.Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders.Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review.Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database.Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: A multi-center study.Application of Multiplex Biomarker Approaches to Accelerate Drug Discovery and Development.Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development.Predicting serious rare adverse reactions of novel chemicals.Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.The Burden of Hepatobiliary Diseases in Portugal: What Can We Learn from Mortality Data.A side-effect free method for identifying cancer drug targets.Can BSEP Inhibition Testing In Drug Discovery And Development Reduce Liver Injury Risk? - An International Transporter Consortium PerspectivePerceptions of French general practitioners and patients regarding dextropropoxyphene withdrawal: a qualitative studyPatterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in NigeriaCanadian status of "drugs to avoid" in 2017: a descriptive analysisA Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents
P2860
Q28068710-4EB2145F-82AC-40CC-91F1-73D973BA0B3FQ28468389-36155EEF-5B4F-46E4-BD0D-CBE4C1E82472Q33704765-62456316-3DEA-4E67-AB3E-5D895047459CQ35922956-74CC1F4C-1958-4D29-AA0A-CB2ACAA6813AQ36206061-2DC26AA6-9657-4748-BF31-81F5A45571A3Q36313915-C7165F54-0C5F-4192-BB3B-6FC429A06E2CQ38672541-6E49B1F5-8387-4EDD-AF7D-AF4AA5C8DD4AQ38760114-E2600E0D-C132-4938-BA60-9D3EBC399B26Q40970686-963D607B-4F55-4F31-80F1-7169AC4746A7Q42361532-264D0F40-A7A4-4D27-97E5-7C15B1350DDEQ42461906-CEDE69CF-76BB-4640-BE3D-8F6C2E9E17DEQ46801702-63BC9FBF-3E71-4738-A8C6-685D34359E68Q47142191-CF39986A-7EEE-43D1-AC08-ACC4B4DC542FQ47142232-7FE3D3DF-D2DA-4FBC-AD5D-45C8AF673C46Q47225797-F444C910-100C-4283-9234-220EF6484D51Q47278228-CD2F8AE5-BE20-4005-BC59-9F5EDC3E08CBQ47557278-B0888C2B-992C-4A76-8860-07F603010DE3Q47715976-A35BFFD0-CC85-4DE1-B833-C396B9B4F429Q47763396-60FF0984-77B9-410C-8643-4B874AB4B524Q47873737-E765DC3B-A716-4D87-8266-2A10D0512972Q48197937-99B674EA-B3AC-46F6-9844-5019D5FE878AQ50062827-D5DF4720-BA0D-482B-BB6B-C99D5070794AQ51091535-FD249C9D-C5F6-4A32-A6BB-3DD50946AF4CQ51418460-2CDA59A0-96A5-4285-BFB4-B1947D59245FQ52607238-CBF33EBA-4B2F-4E57-BFD8-D33DABC8C35AQ52669418-0D96F7D7-3692-4D87-89BE-AC6EA051CA57Q54967255-ED847CEA-3229-483B-A694-C5179303DDD4Q55383363-2E9D34C8-367C-49D7-9254-F3B03B60C207Q57111135-F3CCA526-C946-4CCE-88C0-687CA48E08D5Q57152741-BCE17349-8551-4D08-A772-571B6D9B3ED0Q57488998-0AC89404-E978-4D94-A131-60E731DC45AFQ58697277-D08170A0-0356-4A82-8183-3CE64A379448Q58787671-7E34F361-51AE-4549-8BB9-AA23B5359ED2
P2860
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Post-marketing withdrawal of 4 ...... review of the world literature
@ast
Post-marketing withdrawal of 4 ...... review of the world literature
@en
Post-marketing withdrawal of 4 ...... review of the world literature
@nl
type
label
Post-marketing withdrawal of 4 ...... review of the world literature
@ast
Post-marketing withdrawal of 4 ...... review of the world literature
@en
Post-marketing withdrawal of 4 ...... review of the world literature
@nl
prefLabel
Post-marketing withdrawal of 4 ...... review of the world literature
@ast
Post-marketing withdrawal of 4 ...... review of the world literature
@en
Post-marketing withdrawal of 4 ...... review of the world literature
@nl
P2860
P31
P3181
P1433
P1476
Post-marketing withdrawal of 4 ...... review of the world literature
@en
P2093
Carl J Heneghan
Igho J Onakpoya
P2860
P2888
P3181
P356
10.1186/S12916-016-0553-2
P407
P577
2016-01-01T00:00:00Z
2016-02-04T00:00:00Z
P5875
P6179
1051507374